Sign Up

Your Profile will be reviewed by Admin
TODAY : Advanced Search
Jul 2016


Google Map

Preparation for GMP Inspections by Regulatory Agencies

Online Event


This GMP inspections webinar will review what to expect during the agency inspection and how to successfully and efficiently streamline and manage the inspection, including adequate follow-up during and after the inspection.

Why Should You Attend:
Regulatory agencies conduct product-related GMP inspections when assessing an application for marketing approval. This inspection checks if the manufacturer complies with GMP principles and practices from ICH and the local region.
Product-related inspections may also be conducted if the agency is informed or suspects a possible GMP breach. This may be triggered by a whistle blower, an inspection for other products manufactured in the facility, or inspections conducted by other regulatory authorities.
Inspections may be announced or conducted spontaneously.
This webinar will provide practical tips and advice for ensuring that all inspections are conducted in the most effective and efficient way possible, including ongoing readiness for inspections, rehearsals and preparation for successful facility inspections, and response to findings by regulatory agencies.

Who Will Benefit:
The following professionals from all FDA regulated industries will benefit from this training:
Design Engineers
Supply chain
Technical operations
Quality control
Quality assurance
Regulatory affairs

Instructor Profile:
Peggy J. Berry, MBA, RAC, is the president and CEO at Synergy Consulting where she provides consulting services to companies in all aspects of drug development. She also provides group and one-on-one training in drug development, regulatory affairs and project management topics.
Prior to founding Synergy Consulting in 2015, she was vice president of regulatory affairs at Insmed (2/2015-5/2015) where she was responsible for the development and implementation of global regulatory strategies and the management and oversight of the regulatory affairs department. Prior to Insmed, she was vice president of regulatory affairs and quality at Amarin (3/2009-2/2014). She has also held a variety of senior level positions at Dyax (5/2006-3/2009), MGI Pharma (now Eisai; 7/2005-5/2006), AstraZeneca (10/2001-7/2005), and Dey Pharma (now Mylan; 12/1997-10/2001). She has also held regulatory affairs roles within two clinical contract research organizations (ILEX Oncology and Cato Research Ltd; 1992-1997) and has worked in review divisions at the FDA (1985-1992).

Use coupon code NB5SQH8N and get 10% off on registration.

For Registration:



MORE events +